Sign inGet started

KIM PETER S

Insider CIK 1181180 · TRDA Director · MRK Exe V-P & Pres, MRL

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
TRDA Entrada Therapeutics, Inc. A Award deriv2026-06-102026-06-1219,000— $019,000SEC↗
TRDA Entrada Therapeutics, Inc. A Award deriv2025-06-112025-06-1219,000— $019,000SEC↗
TRDA Entrada Therapeutics, Inc. A Award deriv2024-06-132024-06-1416,000— $016,000SEC↗
TRDA Entrada Therapeutics, Inc. M Exercise deriv2024-06-032024-06-0511,918— $00SEC↗
TRDA Entrada Therapeutics, Inc. M Exercise2024-06-032024-06-0511,918$6.06 $72.2K104,330SEC↗
TRDA Entrada Therapeutics, Inc. P Buy2024-05-142025-06-1825,000$14.59 $364.8K117,412SEC↗
TRDA Entrada Therapeutics, Inc. P Buy2024-05-142024-05-1625,000$14.59 $364.8K92,412SEC↗
TRDA Entrada Therapeutics, Inc. P Buy2024-05-132025-06-1825,000$14.68 $367.0K92,412SEC↗
TRDA Entrada Therapeutics, Inc. P Buy2024-05-092024-05-102,200$14.25 $31.4K67,412SEC↗
TRDA Entrada Therapeutics, Inc. P Buy2024-05-082024-05-102,276$14.04 $32.0K65,212SEC↗
TRDA Entrada Therapeutics, Inc. P Buy2024-04-082024-04-102,600$13.57 $35.3K62,936SEC↗
TRDA Entrada Therapeutics, Inc. P Buy2024-03-282024-04-011,512$13.75 $20.8K60,336SEC↗
TRDA Entrada Therapeutics, Inc. P Buy2024-03-262024-03-262,750$13.64 $37.5K58,824SEC↗
TRDA Entrada Therapeutics, Inc. P Buy2024-03-252024-03-263,180$13.36 $42.5K56,074SEC↗
TRDA Entrada Therapeutics, Inc. P Buy2024-03-222024-03-263,118$13.76 $42.9K52,894SEC↗
TRDA Entrada Therapeutics, Inc. P Buy2024-03-212024-03-21704$13.24 $9.3K49,776SEC↗
TRDA Entrada Therapeutics, Inc. P Buy2024-03-202024-03-211,128$12.66 $14.3K49,072SEC↗
TRDA Entrada Therapeutics, Inc. P Buy2024-03-192024-03-21900$12.66 $11.4K47,944SEC↗
TRDA Entrada Therapeutics, Inc. A Award deriv2023-06-082023-06-1216,000— $016,000SEC↗
TRDA Entrada Therapeutics, Inc. A Award deriv2022-06-022022-06-0611,918— $011,918SEC↗
TRDA Entrada Therapeutics, Inc. A Award deriv2021-10-282021-11-0111,918— $011,918SEC↗
MRK Merck & Co. Inc. A Award2013-02-252013-02-2718,903$42.52 $803.8K189,609SEC↗
MRK Merck & Co. Inc. M Exercise deriv2012-11-052012-11-06100,000— $00SEC↗
MRK Merck & Co. Inc. M Exercise deriv2012-11-052012-11-06224,000— $00SEC↗
MRK Merck & Co. Inc. M Exercise deriv2012-11-052012-11-0696,000— $00SEC↗
MRK Merck & Co. Inc. M Exercise2012-11-052012-11-06224,000$23.45 $5.25M394,706SEC↗
MRK Merck & Co. Inc. S Sale2012-11-052012-11-06420,000$45.50 $19.11M170,706SEC↗
MRK Merck & Co. Inc. M Exercise2012-11-052012-11-0696,000$35.09 $3.37M590,706SEC↗
MRK Merck & Co. Inc. M Exercise2012-11-052012-11-06100,000$31.84 $3.18M494,706SEC↗
MRK Merck & Co. Inc. A Award deriv2012-05-022012-05-0415,271— $015,271SEC↗
MRK Merck & Co. Inc. A Award deriv2012-05-022012-05-04219,378— $0219,378SEC↗
MRK Merck & Co. Inc. G Gift2012-05-022012-05-0410,000— $0170,706SEC↗
MRK Merck & Co. Inc. A Award2012-02-282012-03-0116,701$38.38 $641.0K180,706SEC↗